Pr-Set7 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Pr-Set7 monoclonal antibodies for research focused on understanding this important methyltransferase. Pr-Set7 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pr-Set7, also known as SETD8, is a histone methyltransferase that specifically methylates histone H4 at lysine 20, playing a crucial role in the regulation of gene expression and cell cycle progression. The function of Pr-Set7 is vital for maintaining genomic stability and influencing cellular differentiation, making it a significant target for studies related to cancer and developmental biology. Understanding Pr-Set7 mechanisms can provide insights into epigenetic regulation and its implications in various diseases. Researchers worldwide utilize Pr-Set7 monoclonal antibodies to advance their studies in chromatin modification and cell cycle control. The specificity and reliability of Pr-Set7 monoclonal antibodies enable detailed examination of methylation patterns and their biological significance. Each Pr-Set7 monoclonal antibody undergoes quality control to ensure consistent performance across multiple experimental applications. Santa Cruz Biotechnology monoclonal antibodies for Pr-Set7 continue to support breakthrough discoveries in epigenetic research and disease understanding.